Last reviewed · How we verify

NCT07223710

Improving Walking After Spinal Cord Injury

Not yet recruiting Phase 1, PHASE2 Last updated 3 November 2025
What this trial tests

Phase 1, PHASE2 trial testing Paired Associative Stimulation in Spinal Cord Injury in 20 participants. Not yet recruiting.

Timeline
15 November 2025
Primary endpoint
30 March 2026
30 July 2026

Quick facts

Lead sponsorShirley Ryan AbilityLab
PhasePhase 1, PHASE2
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date15 November 2025
Primary completion30 March 2026
Estimated completion30 July 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Shirley Ryan AbilityLab — full company profile →

Who can join

Adults 18 to 75, any sex, with Spinal Cord Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Locomotor recovery is one of the most important goals of individuals with spinal cord injury (SCI). Ambulatory deficits severely impact daily functions resulting in lower quality of life for people living with paralysis due to SCI. Although studies have shown that locomotor training improves locomotor function in people with chronic SCI, the benefits remain limited. Our overall hypothesis is that we can engage additional descending motor pathways, such as the reticulospinal tract (RST), to improve locomotor function in humans with chronic incomplete SCI. In this study we propose to test the effects of a novel intervention that uses repeated paired loud auditory and electrical stimulation of muscle afferents combined with locomotor training on walking speed and voluntary muscle strength.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Paired Associative Stimulation

Trials testing the same drug.

Other recruiting trials for Spinal Cord Injury

Currently open trials in the same condition.

Other Shirley Ryan AbilityLab trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07223710.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing